EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Significance of an Early Repeat Troponin Measurement Upon Presentation to the Hospital for Acute Heart Failure

Yu Horiuchi iD, Alan S Maisel, Dirk J van Veldhuisen iD, Christian Mueller iD, Christopher Hogan iD, Michael C Kontos, Chad M Cannon iD, Gerhard A Müller iD, Pam Taub iD, Gary M Vilke iD, Stephen Duff iD, Kenneth McDonald und 6 weitere

Journal of the American Heart Association · 2024

DOI: 10.1161/jaha.124.034850 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Yu Horiuchi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology Mitsui Memorial Hospital Tokyo Japan. Hauptthemen laut MEDLINE: Heart Failure, Biomarkers, Troponin I. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CSRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Higher cardiac troponin is associated with worse outcomes in patients with acute heart failure. The significance of repeat measurements over hours remains unclear. We assessed whether a repeat measurement and the Δ between measurements of high‐sensitivity cardiac troponin I (hs‐cTnI) were associated with outcomes in hypervolemic patients with acute heart failure without acute coronary syndrome. Methods and Results We analyzed 582 individuals from AKINESIS (Acute Kidney Injury Neutrophil Gelatinase‐Associated Lipocalin Evaluation of Symptomatic Heart Failure Study) with hs‐cTnI measured ≤12 hours from admission and repeated ≤6 hours thereafter. Associations between hs‐cTnI levels and their Δ with short‐term (death, intensive care unit admission, receipt of inotropes, or positive pressure ventilation during hospitalization) and long‐term (death or heart failure readmission within 1 year) outcomes were assessed. The average age was 69±13 years, 62% were men, 65% were White, 46% had coronary artery disease, and 22% had chest pain. Median hs‐cTnI levels were 27 (interquartile range [IQR], 13–62) ng/L initially and 28 (IQR, 14–68) ng/L subsequently, with a Δ of 0 [IQR, −2 to 4] ng/L over 3.4±1 hours. Only the second measurement was associated with short‐term outcomes (odds ratio, 1.14 per 2‐fold higher [95% CI, 1.02–1.28]). Both individual measurements and the Δ were associated with long‐term outcomes (hazard ratios, 1.09, 1.12, and 1.16 for first, second, and Δ, respectively). Associated risk for the first and second measurements were not constant over the year but highest early after being measured and decreased over 1 year.

Conclusions

Repeat measurements of hs‐cTnI over hours can identify individuals with acute heart failure without acute coronary syndrome at risk for short‐ and long‐term outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureBiomarkersTroponin IHumansMaleAgedFemaleAcute DiseaseMiddle AgedTime FactorsAged, 80 and overPrognosisPredictive Value of TestsRisk FactorsProspective StudiesPatient Readmission

Stichwörter der Autor:innen

acute heart failuremyocardial injuryprognosistroponin

Substanzen

BiomarkersTroponin I

Autor:innen und Institutionen

  • Division of Cardiology Mitsui Memorial Hospital Tokyo Japan.
  • Division of Cardiovascular Medicine University of California, San Diego La Jolla CA.
  • Department of Cardiology, University Medical Center Groningen University of Groningen Groningen the Netherlands.
  • Department of Cardiology, University Hospital Basel University of Basel Basel Switzerland.
  • Division of Emergency Medicine and Acute Care Surgical Services, VCU Medical Center Virginia Commonwealth University Richmond VA.
  • Division of Cardiology, VCU Medical Center Virginia Commonwealth University Richmond VA.

ORCID-Profile: Yu Horiuchi, Dirk J van Veldhuisen, Christian Mueller, Christopher Hogan, Chad M Cannon, Gerhard A Müller, Pam Taub, Gary M Vilke, Stephen Duff, Niall Mahon, Julio Nuñez, Carlo Briguori, Claudio Passino, Patrick T Murray, Nicholas Wettersten

Förderung

  • CSRD VA

Zitieren

APA

Horiuchi, Y., Maisel, A. S., van Veldhuisen, D. J., Mueller, C., Hogan, C., Kontos, M. C., Cannon, C. M., Müller, G. A., Taub, P., Vilke, G. M., Duff, S., McDonald, K., Mahon, N., Nuñez, J., Briguori, C., Passino, C., Murray, P. T., & Wettersten, N. (2024). Significance of an Early Repeat Troponin Measurement Upon Presentation to the Hospital for Acute Heart Failure. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.034850

Vancouver

Horiuchi Y, Maisel AS, van Veldhuisen DJ, Mueller C, Hogan C, Kontos MC, et al. Significance of an Early Repeat Troponin Measurement Upon Presentation to the Hospital for Acute Heart Failure. Journal of the American Heart Association. 2024. doi:10.1161/jaha.124.034850

BibTeX
@article{Horiuchi2024,
  author = {Horiuchi, Yu and Maisel, Alan S and van Veldhuisen, Dirk J and Mueller, Christian and Hogan, Christopher and Kontos, Michael C and Cannon, Chad M and Müller, Gerhard A and Taub, Pam and Vilke, Gary M and Duff, Stephen and McDonald, Kenneth and Mahon, Niall and Nuñez, Julio and Briguori, Carlo and Passino, Claudio and Murray, Patrick T and Wettersten, Nicholas},
  title = {Significance of an Early Repeat Troponin Measurement Upon Presentation to the Hospital for Acute Heart Failure},
  journal = {Journal of the American Heart Association},
  year = {2024},
  doi = {10.1161/jaha.124.034850}
}
Kostenlos starten →